0000950170-24-091964.txt : 20240806
0000950170-24-091964.hdr.sgml : 20240806
20240806170003
ACCESSION NUMBER: 0000950170-24-091964
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240802
FILED AS OF DATE: 20240806
DATE AS OF CHANGE: 20240806
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sullivan Lynne Marie
CENTRAL INDEX KEY: 0001727640
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38470
FILM NUMBER: 241180266
MAIL ADDRESS:
STREET 1: C/O SOLID BIOSCIENCES, LLC
STREET 2: 141 PORTLAND STREET, FIFTH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Unity Biotechnology, Inc.
CENTRAL INDEX KEY: 0001463361
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 264726035
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 285 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 416-1192
MAIL ADDRESS:
STREET 1: 285 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Cenexys, Inc.
DATE OF NAME CHANGE: 20130703
FORMER COMPANY:
FORMER CONFORMED NAME: Forge Inc
DATE OF NAME CHANGE: 20090504
4
1
ownership.xml
4
X0508
4
2024-08-02
0001463361
Unity Biotechnology, Inc.
UBX
0001727640
Sullivan Lynne Marie
285 EAST GRAND AVE
SOUTH SAN FRANCISCO
CA
94080
false
true
false
false
CFO & Head of Corp. Dev.
false
Common Stock, $0.0001 par value
2024-08-02
4
S
false
139
1.53
D
56061
D
Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading instruction to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
Includes Restricted Stock Units which vest over time measured from the grant date.
Represents adjusted total that includes an aggregate of 23,515 shares purchased under the Unity Biotechnology, Inc. 2018 Employee Stock Purchase Plan on May 15, 2023 and May 15, 2024 in transactions exempt from reporting pursuant to Rule 16b-3(c).
/s/ Alexander Nguyen, Attorney-in-Fact for Lynne Sullivan
2024-08-06